Pharma-grade from day one.
Optimi operates a Health Canada GMP-compliant facility in Princeton, British Columbia, authorized for the commercial manufacture, packaging, testing, and international export of controlled drug products.
Each lot is produced under a Drug Establishment Licence, tested by HPLC and mass spectrometry, and released by a Qualified Person in accordance with Health Canada GMP requirements.
API synthesis
Natural or synthetic psilocybin; synthetic MDMA HCl. Produced under GMP; tested by HPLC and mass spectrometry.
Formulation
Finished-dose oral capsules at specified strength. Uniformity and dissolution tested per USP.
QP release
Each lot reviewed and released by a Qualified Person. Labeled per Health Canada DEL requirements.
Permit export
Under international narcotic export permit to authorized importer in destination country.
Clinic dispense
Dispensed to patient by authorized prescriber within a regulated therapy program.